Pharma

Fortis Healthcare Ltd

FORTIS · NSE · INE061F01013
₹914-0.11%consolidatedstandalone
Wednesday, 9 Sept 20262:31 pm
Sentiment35 · Fear
Extreme FearFearNeutralGreedExtreme Greed
Market Cap
P/E
P/B
EPS
Div Yield
ROE11.3%
ROCE10.0%
ROE11.3%
1Y Return+0.66%
Avg. Volume1.4M

Price Chart

1,0981,0219438667893.0Cr5.9CrSept 2025Oct 2025Nov 2025Jan 2026Feb 2026Mar 2026May 2026Jul 2026Sept 2026

52-Week Range

₹766.8₹914₹1,104.3
52W Low52W High

About

Fortis Healthcare Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap
Current Price₹914
52W High / Low₹1,104.3 / ₹766.8
Stock P/E
Price to Book
EPS (TTM)
Dividend Yield
ROE11.3%
1Y Return+0.66%
Day Change-0.11%
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹9,506 Cr₹9,128 Cr₹7,783 Cr
Expenses₹7,375 Cr₹7,043 Cr₹6,195 Cr
Operating Profit₹2,131 Cr₹2,085 Cr₹1,588 Cr
OPM %22.0%23.0%20.0%
Other Income₹42 Cr₹45 Cr₹-11 Cr
Depreciation₹470 Cr₹449 Cr₹386 Cr
Interest₹325 Cr₹314 Cr₹184 Cr
Profit Before Tax₹1,378 Cr₹1,366 Cr₹1,007 Cr
Tax₹308 Cr₹302 Cr₹198 Cr
Net Profit₹1,070 Cr₹1,064 Cr₹809 Cr
EPS (₹)13.913.810.3
Dividend Payout %7%10%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹2,545 Cr₹2,365 Cr₹2,265 Cr₹2,331 Cr
Expenses₹2,008 Cr₹1,832 Cr₹1,759 Cr₹1,775 Cr
Operating Profit₹537 Cr₹532 Cr₹506 Cr₹556 Cr
OPM %21.0%23.0%22.0%24.0%
Depreciation₹122 Cr₹122 Cr₹120 Cr₹106 Cr
Interest₹80 Cr₹84 Cr₹86 Cr₹75 Cr
Net Profit₹273 Cr₹271 Cr₹197 Cr₹329 Cr
EPS (₹)3.53.52.64.3
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹755 Cr₹755 Cr₹755 Cr
Reserves₹9,141 Cr₹8,162 Cr₹6,908 Cr
Borrowings₹3,473 Cr₹2,475 Cr₹1,155 Cr
Other Liabilities₹2,464 Cr₹1,985 Cr₹4,153 Cr
Total Liabilities₹15,833 Cr₹13,377 Cr₹12,971 Cr
Assets
Fixed Assets₹12,230 Cr₹10,424 Cr₹9,874 Cr
Investments₹243 Cr₹169 Cr₹230 Cr
Receivables
Inventory
Cash & Equivalents
Other Assets₹2,926 Cr₹2,378 Cr₹2,326 Cr
Total Assets₹15,833 Cr₹13,377 Cr₹12,971 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹1,601 Cr₹-1,537 Cr₹164 Cr₹228 Cr
FY25₹1,424 Cr₹-780 Cr₹-714 Cr₹-70 Cr
FY24₹1,100 Cr₹-889 Cr₹-86 Cr₹125 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
Sun Pharmaceutical Industries Ltd+14.78%+7.18%
Dr Reddys Laboratories Ltd+8.84%-3.74%
Cipla Ltd+11.77%-5.50%
Apollo Hospitals Enterprise Ltd+22.64%+23.01%
Divis Laboratories Ltd₹2,50,065 Cr83.9+16.5%+46.29%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.